Cargando…
New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer
Adrenocortical cancer (ACC) is a rare aggressive malignancy. Recent ACC integrated genomics analysis contributed to redefine the risk groups on molecular basis, including tumor microRNAs (miRs), detectable also in the bloodstream. We developed a quantitative real-time (RT) assay for the measurement...
Autores principales: | Salvianti, Francesca, Canu, Letizia, Poli, Giada, Armignacco, Roberta, Scatena, Cristian, Cantini, Giulia, Di Franco, Alessandra, Gelmini, Stefania, Ercolino, Tonino, Pazzagli, Mario, Nesi, Gabriella, Mannelli, Massimo, Pinzani, Pamela, Luconi, Michaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630350/ https://www.ncbi.nlm.nih.gov/pubmed/29029450 http://dx.doi.org/10.18632/oncotarget.19118 |
Ejemplares similares
-
Prognostic and Monitoring Value of Circulating Tumor Cells in Adrenocortical Carcinoma: A Preliminary Monocentric Study
por: Cantini, Giulia, et al.
Publicado: (2020) -
2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma
por: Poli, Giada, et al.
Publicado: (2015) -
Metformin as a new anti-cancer drug in adrenocortical carcinoma
por: Poli, Giada, et al.
Publicado: (2016) -
Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer
por: Cantini, Giulia, et al.
Publicado: (2021) -
The Adipose Stem Cell as a Novel Metabolic Actor in Adrenocortical Carcinoma Progression: Evidence from an In Vitro Tumor Microenvironment Crosstalk Model
por: Armignacco, Roberta, et al.
Publicado: (2019)